Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

18.04
Delayed Data
As of Mar 24
 +0.07 / +0.39%
Today’s Change
14.27
Today|||52-Week Range
18.22
+12.26%
Year-to-Date
Who Will Win the March Madness of Trump Stocks?
Mar 23 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal
Mar 20 / Zacks.com - Paid Partner Content
5 Cheap PEG Picks for Value Investors Right Now
Mar 22 / Zacks.com - Paid Partner Content
Is Grifols a Great Stock for Value Investors?
Mar 17 / Zacks.com - Paid Partner Content
Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod
Mar 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close17.97
Today’s open18.10
Day’s range17.99 - 18.22
Volume620,219
Average volume (3 months)709,999
Market cap$4.6B
Dividend yield3.04%
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+3.24%
Earnings growth (this year)--
Earnings growth (next 5 years)+11.95%
Revenue growth (last year)+2.94%
P/E ratio--
Price/Sales2.46
Price/Book3.14

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-0.70-1.33%
MNKMallinckrodt Plc-0.09-0.21%
TAROTaro Pharmaceutical ...+0.17+0.15%
IONSIonis Pharmaceutical...+1.05+2.77%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$4.5B
Annual profit (last year)$602.1M
Net profit margin13.47%

Profile

Sector
Health Technology
Industry
Biotechnology
Joint Chief Executive Officer &
Director
Raimon Grifols Roura
Joint Chief Executive Officer &
Director
Victor Grifols Deu
Corporate headquarters
Barcelona, Catalonia

Forecasts


Search for Jobs